Table 2 Values of mfERG in five rings in patients and control groups
MfERG Rings | Patients (n = 30) | Controls (n = 30) | P-value |
|---|---|---|---|
RT R1 amplitude | 57.08 (16.48) | 102.09 (25.67) | < 0.001* |
RT R1 peak time | 47.14 (4.28) | 42.23 (4.17) | < 0.001* |
LT R1 amplitude | 52.02 (16.25) | 100.48 (23.13) | < 0.001* |
LT R1 peak time | 46.16 (3.5) | 41.59 (4.43) | < 0.001* |
RT R2 amplitude | 29.27 (9.5) | 41.96 (7.33) | < 0.001* |
RT R2 peak time | 45.35 (3.24) | 42.3 (3.71) | 0.001* |
LT R2 amplitude | 26.58 (8.32) | 42.27 (8.81) | < 0.001* |
LT R2 peak time | 45.28 (2.54) | 43.25 (3.24) | 0.009* |
RT R3 amplitude | 19.01 (5.11) | 26.6 (4.15) | < 0.001* |
RT R3 peak time | 44.26 (2.58) | 43.61 (2.40) | 0.315 |
LT R3 amplitude | 18.99(4.47) | 25.54 (3.32) | < 0.001* |
LT R3 peak time | 44.18 (3.36) | 42.47 (3.47) | 0.058 |
RT R4 amplitude | 12.14 (3.80) | 16.34 (4.16) | < 0.001* |
RT R4 peak time | 43.61 (2.80) | 43.18 (2.61) | 0.541 |
LT R4 amplitude | 12.25 (3.63) | 15.66 (3.69) | 0.001* |
LT R4 peak time | 42.90 (3.86) | 42.5 (3.6) | 0.685 |
RT R5 amplitude | 10.16 (3.47) | 12.77 (2.77) | 0.002* |
RT R5 peak time | 43.22 (2.46) | 43.06 (1.93) | 0.772 |
LT R5 amplitude | 9.26 (2.62) | 12.29 (2.94) | < 0.001* |
LT R5 peak time | 43.42 (2.16) | 42.49 (3.09) | 0.185 |